Details

Autor(en) / Beteiligte

• Yelin, Dana
• Wirtheim, Eytan
• Vetter, Pauline
• Kalil, Andre C
• Bruchfeld, Judith
• Runold, Michael
• Guaraldi, Giovanni
• Mussini, Cristina
• Gudiol, Carlota
• Pujol, Miquel
• Bandera, Alessandra
• Scudeller, Luigia
• Paul, Mical
• Kaiser, Laurent
• Leibovici, Leonard

Titel

Long-term consequences of COVID-19: research needs

Ist Teil von

• The Lancet infectious diseases, 2020-10, Vol.20 (10), p.1115-1117

Ort / Verlag

United States: Elsevier Ltd

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Paul Garner, a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on the 95th day after the onset of symptoms that “I am unable to be out of bed for more than three hours at a stretch, my arms and legs are permanently fizzing as if injected with Szechuan peppercorns, I have ringing in the ears, intermittent brain fog, palpitations, and dramatic mood swings.” 1 Other people also describe similar complaints.2,3 78 of 100 patients in an observational cohort study who had recovered from COVID-19 had abnormal findings on cardiovascular MRI (median of 71 days after diagnosis) and 36 of those reported dyspnoea and unusual fatigue.4 We are seeing patients in clinics dedicated to COVID-19 convalescents, and for some of these patients the return to their former health trajectory is slow and painful. To avoid the problems we have witnessed in the research of the acute phase of the disease, a clear definition of patient inclusion criteria, a common protocol, and uniform definitions of outcomes and ways to measure them are required.